DK1126874T3 - Multikomponent Meningococcus Vaccine - Google Patents
Multikomponent Meningococcus VaccineInfo
- Publication number
- DK1126874T3 DK1126874T3 DK99954130T DK99954130T DK1126874T3 DK 1126874 T3 DK1126874 T3 DK 1126874T3 DK 99954130 T DK99954130 T DK 99954130T DK 99954130 T DK99954130 T DK 99954130T DK 1126874 T3 DK1126874 T3 DK 1126874T3
- Authority
- DK
- Denmark
- Prior art keywords
- multicomponent
- meningococcus vaccine
- meningococcus
- vaccine
- outer membrane
- Prior art date
Links
- 229960005486 vaccine Drugs 0.000 title 1
- 239000012528 membrane Substances 0.000 abstract 2
- 241000588650 Neisseria meningitidis Species 0.000 abstract 1
- 230000000890 antigenic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/095—Neisseria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9823978.3A GB9823978D0 (en) | 1998-11-02 | 1998-11-02 | Multicomponent meningococcal vaccine |
PCT/GB1999/003626 WO2000025811A2 (en) | 1998-11-02 | 1999-11-02 | Multicomponent meningococcal vaccine |
Publications (3)
Publication Number | Publication Date |
---|---|
DK1126874T3 true DK1126874T3 (da) | 2003-09-29 |
DK1126874T4 DK1126874T4 (da) | 2008-10-13 |
DK1126874T5 DK1126874T5 (da) | 2008-12-01 |
Family
ID=10841713
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK99954130T DK1126874T5 (da) | 1998-11-02 | 1999-11-02 | Multikomponent Meningococcus Vaccine |
Country Status (13)
Country | Link |
---|---|
US (2) | US6821521B1 (da) |
EP (3) | EP1126874B2 (da) |
JP (2) | JP2002528515A (da) |
AT (1) | ATE242640T1 (da) |
AU (1) | AU760858B2 (da) |
BR (1) | BR9914946A (da) |
CA (1) | CA2349331A1 (da) |
DE (1) | DE69908805T3 (da) |
DK (1) | DK1126874T5 (da) |
ES (1) | ES2197688T5 (da) |
GB (1) | GB9823978D0 (da) |
PT (1) | PT1126874E (da) |
WO (1) | WO2000025811A2 (da) |
Families Citing this family (53)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030215469A1 (en) * | 1998-11-02 | 2003-11-20 | Microbiological Research Authority | Multicomponent meningococcal vaccine |
GB9823978D0 (en) * | 1998-11-02 | 1998-12-30 | Microbiological Res Authority | Multicomponent meningococcal vaccine |
US10967045B2 (en) | 1998-11-02 | 2021-04-06 | Secretary of State for Health and Social Care | Multicomponent meningococcal vaccine |
US7081244B2 (en) | 1999-02-22 | 2006-07-25 | Health Protection Agency | Neisserial vaccine compositions and methods |
JP4982009B2 (ja) * | 1999-02-22 | 2012-07-25 | ヘルス プロテクション エージェンシー | ナイセリアワクチン組成物および方法 |
DK2270173T3 (da) | 1999-05-19 | 2016-03-07 | Glaxosmithkline Biolog Sa | Neisseriale kombinationssammensætninger |
DK1248647T3 (da) | 2000-01-17 | 2010-09-27 | Novartis Vaccines & Diagnostic | Ydre membranvesikel (OMV) vaccine omfattende N. meningitidis serogruppe B ydre membranproteiner |
MXPA03000822A (es) | 2000-07-27 | 2004-11-01 | Childrens Hosp & Res Ct Oak | Vacunas para proteccion de espectro amplio contra enfermedades causadas por neisseria meningitidis. |
GB0130123D0 (en) * | 2001-12-17 | 2002-02-06 | Microbiological Res Agency | Outer membrane vesicle vaccine and its preparation |
PT2255826E (pt) * | 2002-08-02 | 2016-06-08 | Glaxosmithkline Biologicals Sa | Composições de vacina de neisseria compreendendo uma combinação de antigénios |
GB0220194D0 (en) | 2002-08-30 | 2002-10-09 | Chiron Spa | Improved vesicles |
ES2608048T3 (es) | 2002-10-11 | 2017-04-05 | Glaxosmithkline Biologicals Sa | Vacunas polipeptídicas para protección amplia contra linajes meningocócicos hipervirulentos |
US20070059329A1 (en) | 2002-11-15 | 2007-03-15 | Nathalie Norais | Unexpected surface proteins in meningococcus |
GB0227346D0 (en) | 2002-11-22 | 2002-12-31 | Chiron Spa | 741 |
CA2514328C (en) | 2003-01-30 | 2020-01-14 | Chiron Srl | Injectable vaccines against multiple meningococcal serogroups |
GB0323103D0 (en) | 2003-10-02 | 2003-11-05 | Chiron Srl | De-acetylated saccharides |
CU23377A1 (es) * | 2003-11-04 | 2009-05-28 | Ct De Ingenieria Genetica Y Biotecnologia | Metodo para la incorporacion de antigenos en vesiculas de membrana externa de bacterias y formulaciones resultantes |
GB0424092D0 (en) | 2004-10-29 | 2004-12-01 | Chiron Srl | Immunogenic bacterial vesicles with outer membrane proteins |
CN101107007B (zh) | 2005-01-27 | 2011-08-17 | 奥克兰儿童医院及研究中心 | 对脑膜炎奈瑟球菌所致疾病具有广谱保护作用的gna1870囊泡疫苗 |
GB0524066D0 (en) | 2005-11-25 | 2006-01-04 | Chiron Srl | 741 ii |
US7917240B2 (en) | 2006-09-29 | 2011-03-29 | Fisher-Rosemount Systems, Inc. | Univariate method for monitoring and analysis of multivariate data |
US7378713B2 (en) * | 2006-10-25 | 2008-05-27 | Taiwan Semiconductor Manufacturing Co., Ltd. | Semiconductor devices with dual-metal gate structures and fabrication methods thereof |
GB0700562D0 (en) | 2007-01-11 | 2007-02-21 | Novartis Vaccines & Diagnostic | Modified Saccharides |
DK2200642T3 (da) | 2007-10-19 | 2012-07-16 | Novartis Ag | Meningococvaccinepræparater |
CA2716212A1 (en) | 2008-02-21 | 2009-08-27 | Novartis Ag | Meningococcal fhbp polypeptides |
US8466167B2 (en) | 2008-03-03 | 2013-06-18 | Irm Llc | Compounds and compositions as TLR activity modulators |
JP5723768B2 (ja) | 2008-05-30 | 2015-05-27 | ザ ユナイテッド ステイツ オブ アメリカ, アズ レプレゼンテッド バイ ザ セクレタリー オブ ジ アーミー, オン ビハーフ オブ ウォルター リード アーミー インスティチュート オブ リサーチ | 髄膜炎菌性多価未変性外膜小胞ワクチン、その作製方法およびその使用 |
GB0822634D0 (en) | 2008-12-11 | 2009-01-21 | Novartis Ag | Meningitis vaccines |
CA2747340A1 (en) | 2008-12-17 | 2010-06-24 | Novartis Ag | Meningococcal vaccines including hemoglobin receptor |
WO2010130899A1 (fr) * | 2009-05-14 | 2010-11-18 | Sanofi Pasteur | Vaccin meningocoque a base de lipooligosaccharide (los) et de proteine de neisseria meningitidis |
CA2761916A1 (fr) | 2009-05-14 | 2010-11-18 | Sanofi Pasteur | Procede pour adjuver le lipopolysaccharide (lps) des bacteries a gram-negatif |
CA2765112A1 (en) | 2009-06-10 | 2010-12-16 | Novartis Ag | Benzonaphthyridine-containing vaccines |
CN102740882A (zh) | 2009-08-27 | 2012-10-17 | 诺华有限公司 | 含有铝、寡核苷酸和聚阳离子的佐剂 |
CA2772104A1 (en) | 2009-08-27 | 2011-03-03 | Novartis Ag | Hybrid polypeptides including meningococcal fhbp sequences |
ES2443952T3 (es) | 2009-09-02 | 2014-02-21 | Novartis Ag | Composiciones inmunógenas que incluyen moduladores de la actividad de TLR |
JO3257B1 (ar) | 2009-09-02 | 2018-09-16 | Novartis Ag | مركبات وتركيبات كمعدلات لفاعلية tlr |
GB0916557D0 (en) | 2009-09-21 | 2009-10-28 | Health Prot Agency | Commensal neisserial stress protein complexes |
CN102724988B (zh) | 2009-09-30 | 2014-09-10 | 诺华股份有限公司 | 脑膜炎球菌fHBP多肽的表达 |
CA2779816A1 (en) | 2009-10-27 | 2011-05-05 | Novartis Ag | Modified meningococcal fhbp polypeptides |
WO2011057148A1 (en) | 2009-11-05 | 2011-05-12 | Irm Llc | Compounds and compositions as tlr-7 activity modulators |
US9408907B2 (en) | 2009-12-15 | 2016-08-09 | Glaxosmithkline Biologicals Sa | Homogenous suspension of immunopotentiating compounds and uses thereof |
JP2013521327A (ja) | 2010-03-10 | 2013-06-10 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | 免疫原性組成物 |
CA2793510A1 (en) | 2010-03-18 | 2012-02-16 | Novartis Ag | Adjuvanted vaccines for serogroup b meningococcus |
EP2549990A1 (en) | 2010-03-23 | 2013-01-30 | Irm Llc | Compounds (cystein based lipopeptides) and compositions as tlr2 agonists used for treating infections, inflammations, respiratory diseases etc. |
AU2011300418B2 (en) | 2010-09-10 | 2016-05-12 | Glaxosmithkline Biologicals Sa | Meningococcus overexpressing NadA and/or NHBA and outer membrane vesicles derived therefrom |
WO2012038801A1 (en) | 2010-09-21 | 2012-03-29 | National Institute Of Immunology | A spray dried powder formulation for vaccines entrapping alum and the antigen in biodegradable polymer particles |
WO2012153302A1 (en) | 2011-05-12 | 2012-11-15 | Novartis Ag | Antipyretics to enhance tolerability of vesicle-based vaccines |
GB201110980D0 (en) | 2011-06-28 | 2011-08-10 | Health Prot Agency | Neisserial compositions and expression constructs |
RU2014135522A (ru) | 2012-02-02 | 2016-03-27 | Новартис Аг | Промоторы для увеличенной экспрессии белка у менингококка |
WO2014016152A1 (en) | 2012-07-27 | 2014-01-30 | Institut National De La Sante Et De La Recherche Medicale | Cd147 as receptor for pilus-mediated adhesion of meningococci to vascular endothelia |
US9526776B2 (en) | 2012-09-06 | 2016-12-27 | Glaxosmithkline Biologicals Sa | Combination vaccines with serogroup B meningococcus and D/T/P |
MX2016011176A (es) | 2014-02-28 | 2017-02-23 | Glaxosmithkline Biologicals Sa | Polipeptidos fhbp meningococicos modificados. |
EP3302511A1 (en) * | 2015-06-02 | 2018-04-11 | De Staat der Nederlanden, vert. door de Minister van VWS | Surface display of antigens on gram-negative outer membrane vesicles |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4707543A (en) * | 1985-09-17 | 1987-11-17 | The United States Of America As Represented By The Secretary Of The Army | Process for the preparation of detoxified polysaccharide-outer membrane protein complexes, and their use as antibacterial vaccines |
RU2023448C1 (ru) | 1987-07-30 | 1994-11-30 | Сентро Насьональ Де Биопрепарадос | Способ получения вакцины против различных патогенных серотипов менингита нейссера группы в |
US7118757B1 (en) * | 1988-12-19 | 2006-10-10 | Wyeth Holdings Corporation | Meningococcal class 1 outer-membrane protein vaccine |
AU640118B2 (en) * | 1988-12-19 | 1993-08-19 | De Staat Der Nederlanden Vertegenwoordigd Door De Minister Van Welzijn, Volksgezonheid En Cultuur | Meningococcal class 1 outer-membrane protein vaccine |
US5292869A (en) * | 1989-04-27 | 1994-03-08 | The Board Of Governors Of The University | Method for isolating and purifying transferrin and lactoferrin receptor proteins from bacteria and the preparation of vaccines containing the same |
FR2682041B1 (fr) | 1991-10-03 | 1994-01-14 | Pasteur Merieux Serums Vaccins | Vaccin contre les infections a neisseria meningitidis. |
NL9201716A (nl) * | 1992-10-02 | 1994-05-02 | Nederlanden Staat | Buitenmembraanvesikel dat voorzien is van een groep polypeptiden welke ten minste de immuunwerking van aan membraan gebonden buitenmembraaneiwitten (OMP's) hebben, werkwijze ter bereiding ervan alsmede een vaccin dat een dergelijk buitenmembraanvesikel omvat. |
US6287574B1 (en) * | 1995-03-17 | 2001-09-11 | Biochem Pharma Inc. | Proteinase K resistant surface protein of neisseria meningitidis |
US6180111B1 (en) | 1995-05-18 | 2001-01-30 | University Of Maryland | Vaccine delivery system |
US6558677B2 (en) * | 1996-10-15 | 2003-05-06 | Wendell D. Zollinger | Vaccine against gram negative bacteria |
GB9711964D0 (en) | 1997-06-09 | 1997-08-06 | Medical Res Council | Live attenuated vaccines |
AU748973B2 (en) * | 1997-07-17 | 2002-06-13 | Baxter Healthcare Sa | Immunogenic conjugates comprising a group B meningococcal porin and an H. influenzae polysaccharide |
US10967045B2 (en) * | 1998-11-02 | 2021-04-06 | Secretary of State for Health and Social Care | Multicomponent meningococcal vaccine |
GB9823978D0 (en) * | 1998-11-02 | 1998-12-30 | Microbiological Res Authority | Multicomponent meningococcal vaccine |
DK2270173T3 (da) * | 1999-05-19 | 2016-03-07 | Glaxosmithkline Biolog Sa | Neisseriale kombinationssammensætninger |
GB9918319D0 (en) | 1999-08-03 | 1999-10-06 | Smithkline Beecham Biolog | Vaccine composition |
DK1248647T3 (da) * | 2000-01-17 | 2010-09-27 | Novartis Vaccines & Diagnostic | Ydre membranvesikel (OMV) vaccine omfattende N. meningitidis serogruppe B ydre membranproteiner |
MXPA03000822A (es) * | 2000-07-27 | 2004-11-01 | Childrens Hosp & Res Ct Oak | Vacunas para proteccion de espectro amplio contra enfermedades causadas por neisseria meningitidis. |
GB0130123D0 (en) * | 2001-12-17 | 2002-02-06 | Microbiological Res Agency | Outer membrane vesicle vaccine and its preparation |
PT2255826E (pt) * | 2002-08-02 | 2016-06-08 | Glaxosmithkline Biologicals Sa | Composições de vacina de neisseria compreendendo uma combinação de antigénios |
US20070059329A1 (en) * | 2002-11-15 | 2007-03-15 | Nathalie Norais | Unexpected surface proteins in meningococcus |
GB0227346D0 (en) * | 2002-11-22 | 2002-12-31 | Chiron Spa | 741 |
CA2695467A1 (en) * | 2007-08-02 | 2009-03-26 | Children's Hospital & Research Center At Oakland | Fhbp- and lpxl1-based vesicle vaccines for broad spectrum protection against diseases caused by neisseria meningitidis |
-
1998
- 1998-11-02 GB GBGB9823978.3A patent/GB9823978D0/en not_active Ceased
-
1999
- 1999-11-02 US US09/830,854 patent/US6821521B1/en not_active Expired - Fee Related
- 1999-11-02 WO PCT/GB1999/003626 patent/WO2000025811A2/en active IP Right Grant
- 1999-11-02 EP EP99954130A patent/EP1126874B2/en not_active Expired - Lifetime
- 1999-11-02 EP EP10171629A patent/EP2248535A1/en not_active Ceased
- 1999-11-02 BR BR9914946-0A patent/BR9914946A/pt not_active Application Discontinuation
- 1999-11-02 DE DE69908805T patent/DE69908805T3/de not_active Expired - Lifetime
- 1999-11-02 AT AT99954130T patent/ATE242640T1/de active
- 1999-11-02 CA CA002349331A patent/CA2349331A1/en not_active Abandoned
- 1999-11-02 EP EP02025569A patent/EP1297844A3/en not_active Withdrawn
- 1999-11-02 PT PT99954130T patent/PT1126874E/pt unknown
- 1999-11-02 JP JP2000579250A patent/JP2002528515A/ja active Pending
- 1999-11-02 AU AU10569/00A patent/AU760858B2/en not_active Expired
- 1999-11-02 ES ES99954130T patent/ES2197688T5/es not_active Expired - Lifetime
- 1999-11-02 DK DK99954130T patent/DK1126874T5/da active
-
2008
- 2008-10-20 US US12/289,098 patent/US20090148469A1/en not_active Abandoned
-
2011
- 2011-10-14 JP JP2011227284A patent/JP2012025774A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
ES2197688T5 (es) | 2008-12-16 |
ES2197688T3 (es) | 2004-01-01 |
BR9914946A (pt) | 2001-07-10 |
JP2012025774A (ja) | 2012-02-09 |
DE69908805D1 (de) | 2003-07-17 |
EP1126874A2 (en) | 2001-08-29 |
ATE242640T1 (de) | 2003-06-15 |
EP1126874B1 (en) | 2003-06-11 |
GB9823978D0 (en) | 1998-12-30 |
EP2248535A1 (en) | 2010-11-10 |
AU1056900A (en) | 2000-05-22 |
DE69908805T2 (de) | 2004-05-19 |
DE69908805T3 (de) | 2008-12-24 |
EP1297844A2 (en) | 2003-04-02 |
US20090148469A1 (en) | 2009-06-11 |
WO2000025811A3 (en) | 2000-10-05 |
PT1126874E (pt) | 2003-10-31 |
US6821521B1 (en) | 2004-11-23 |
EP1126874B2 (en) | 2008-06-25 |
CA2349331A1 (en) | 2000-05-11 |
WO2000025811A2 (en) | 2000-05-11 |
DK1126874T4 (da) | 2008-10-13 |
EP1297844A3 (en) | 2004-01-14 |
DK1126874T5 (da) | 2008-12-01 |
JP2002528515A (ja) | 2002-09-03 |
AU760858B2 (en) | 2003-05-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1126874T3 (da) | Multikomponent Meningococcus Vaccine | |
IT1283222B1 (it) | Membrana composita integrale | |
NO951655D0 (no) | Brannmotstandsdyktig treplate med orienterte fibre som konstruksjonselement | |
DE69201113T2 (de) | Aromastoffe enthaltende, orale Peroxid-Bicarbonat Zusammensetzung. | |
DK0741779T3 (da) | Fortykket, stabil, sur rengøringssammensætning i form af en mikroemulsion | |
NO20000202L (no) | Immunogene konjugater som omfatter en gruppe B- meningokokkporin og et H. influenzae-polysakkarid | |
DE69115514D1 (de) | Liposomenhaltige intranasale Impfstofformulierung | |
PL352011A1 (en) | Compositions for dyeing kerating fibres, containing para-phenylenediamine derivatives with pyrrolidinyl group | |
BR9504358A (pt) | Membrana anisotrópica | |
NO972219D0 (no) | Immunogenpreparater | |
FR2749751B1 (fr) | Ensemble moteur-piece a main a contre-angle avec un moteur pas-a-pas | |
FI880819A0 (fi) | Smaeltugn och foerfarande foer matning av det material, som behandlas in i den. | |
ATE109465T1 (de) | 4-aryl-4-piperidine (oder -pyrrolidin- oder - hexahydroazepin-) carbinole und heterocyclische analoga davon. | |
FR2711730B1 (fr) | Turbomachine équipée de moyens de pilotage des jeux entre rotor et stator. | |
ES2146279T3 (es) | 1-ciclopropiltetrazolinonas herbicidas. | |
DE59309355D1 (de) | Neue Phospholipidderivate | |
NO965161L (no) | Tiopyridiner som bekjempelsesmiddel mot heliobacter-bakterier | |
DK0407321T3 (da) | Slåmaskine/konditioneringsapparat forsynet med organer til modifikation af den luftstrøm, der frembringes af skæreorganerne | |
DK53791A (da) | Fremgangsmaade til rensning af sugesystemet, f.eks. sugeslangen, i en tandlaegesugeindretning | |
FR2727965B1 (fr) | 4,4'-(phenylenediisopropyl )-bis- (2.6-dialkylphenylisocyanates) | |
DE29606762U1 (de) | Schrittantrieb | |
NO952255D0 (no) | Rotor med skovler for blandemaskin | |
BR7201977U (pt) | Membrana periodontal. | |
TR26707A (tr) | Tikama tertibatinin sizdirmaz hale getirilmesi. | |
NO883647D0 (no) | Fremgangsmaate for fremstilling av en vaksine mot de forskjellige patogene serotyper av gruppe b neisseria meningitidis. |